Ronald Schmidt

2.6k total citations
40 papers, 2.2k citations indexed

About

Ronald Schmidt is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Ronald Schmidt has authored 40 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 14 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Molecular Biology. Recurrent topics in Ronald Schmidt's work include Inflammatory mediators and NSAID effects (13 papers), Pancreatic function and diabetes (7 papers) and Diabetes Management and Research (6 papers). Ronald Schmidt is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Pancreatic function and diabetes (7 papers) and Diabetes Management and Research (6 papers). Ronald Schmidt collaborates with scholars based in Germany, United States and Italy. Ronald Schmidt's co-authors include Gerd Geißlinger, Sabine Grösch, Thorsten J. Maier, Rudi Busse, M. Michaelis, Ingrid Fleming, Christian Brenneis, Klaus Scholich, R. H. A. Becker and Ovidiu Coste and has published in prestigious journals such as Circulation, Journal of Neuroscience and Diabetes Care.

In The Last Decade

Ronald Schmidt

40 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald Schmidt Germany 25 656 614 534 376 342 40 2.2k
Zhonghua Qi United States 25 490 0.7× 716 1.2× 584 1.1× 455 1.2× 165 0.5× 43 2.3k
Anca D. Dobrian United States 27 537 0.8× 806 1.3× 193 0.4× 292 0.8× 164 0.5× 59 2.7k
Nigishi Hotta Japan 28 676 1.0× 693 1.1× 259 0.5× 135 0.4× 94 0.3× 100 3.3k
Nicole Helbecque France 33 562 0.9× 1.2k 1.9× 196 0.4× 92 0.2× 301 0.9× 90 3.0k
Martin McIntyre United Kingdom 16 1.1k 1.6× 556 0.9× 173 0.3× 315 0.8× 172 0.5× 24 2.6k
Atsuo Goto Japan 35 741 1.1× 1.8k 3.0× 216 0.4× 283 0.8× 132 0.4× 124 4.2k
Akira Uruno Japan 33 525 0.8× 2.1k 3.5× 185 0.3× 227 0.6× 189 0.6× 85 3.4k
Nobuo Sakamoto Japan 25 502 0.8× 649 1.1× 257 0.5× 128 0.3× 77 0.2× 153 2.9k
Harry S. Margolius United States 38 965 1.5× 1.3k 2.0× 556 1.0× 86 0.2× 292 0.9× 102 4.2k
Yuning Huang United States 28 407 0.6× 955 1.6× 290 0.5× 293 0.8× 133 0.4× 42 2.5k

Countries citing papers authored by Ronald Schmidt

Since Specialization
Citations

This map shows the geographic impact of Ronald Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Schmidt more than expected).

Fields of papers citing papers by Ronald Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Schmidt. The network helps show where Ronald Schmidt may publish in the future.

Co-authorship network of co-authors of Ronald Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Schmidt. A scholar is included among the top collaborators of Ronald Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Schmidt. Ronald Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ulrich, Werner, et al.. (2014). Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue. Archives of Physiology and Biochemistry. 120(4). 158–165. 10 indexed citations
2.
Lucidi, Paola, Francesca Porcellati, Paola Candeloro, et al.. (2014). Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study. Nutrition Metabolism and Cardiovascular Diseases. 24(7). 709–716. 19 indexed citations
3.
Tennagels, Norbert, et al.. (2013). Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats. Diabetologia. 56(8). 1826–1834. 13 indexed citations
4.
Varewijck, Aimee J., Hannele Yki‐Järvinen, Ronald Schmidt, Norbert Tennagels, & J. A. M. J. L. Janssen. (2013). Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites, IGF-I, and Human Insulin on Insulin and IGF-I Receptor Signaling. Diabetes. 62(7). 2539–2544. 17 indexed citations
5.
Lechner, Anita, Claudia Bernecker, Renate Horejsi, et al.. (2012). Reduced urinary glutamate levels are associated with the frequency of migraine attacks in females. European Journal of Neurology. 19(8). 1146–1150. 9 indexed citations
6.
Gao, Wei, Achim Schmidtko, Ruirui Lu, et al.. (2009). Prostaglandin D2 sustains the pyrogenic effect of prostaglandin E2. European Journal of Pharmacology. 608(1-3). 28–31. 10 indexed citations
7.
Schiffmann, Susanne, Ronald Schmidt, Kerstin Birod, et al.. (2008). The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis. Journal of Lipid Research. 50(1). 32–40. 59 indexed citations
8.
Maier, Thorsten J., Lars Tausch, Ovidiu Coste, et al.. (2008). Celecoxib inhibits 5-lipoxygenase. Biochemical Pharmacology. 76(7). 862–872. 61 indexed citations
9.
Wobst, Ivonne, Susanne Schiffmann, Kerstin Birod, et al.. (2008). Dimethylcelecoxib inhibits prostaglandin E2 production. Biochemical Pharmacology. 76(1). 62–69. 23 indexed citations
10.
Schmidtko, Achim, Maria Burian, Katja Hardt, et al.. (2007). Pharmacological and histopathological characterization of a hyperalgesia model induced by freeze lesion. Pain. 127(3). 287–295. 7 indexed citations
11.
Metzner, Julia, Claudiu Marian, Ronald Schmidt, et al.. (2007). The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE−/− mice. Journal of Molecular Medicine. 85(6). 623–633. 25 indexed citations
12.
Schuligoi, Rufina, Ronald Schmidt, Gerd Geißlinger, et al.. (2007). PGD2 metabolism in plasma: Kinetics and relationship with bioactivity on DP1 and CRTH2 receptors. Biochemical Pharmacology. 74(1). 107–117. 61 indexed citations
13.
Daniel, Carolin, N Sartory, Nadine Zahn, et al.. (2007). FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Molecular Immunology. 44(13). 3305–3316. 48 indexed citations
14.
Pierre, Sandra, Ronald Schmidt, Christian Brenneis, et al.. (2007). Inhibition of Cyclooxygenases by Dipyrone. British Journal of Pharmacology. 151(4). 494–503. 113 indexed citations
15.
Brenneis, Christian, Ovidiu Coste, Ronald Schmidt, et al.. (2007). Consequences of altered eicosanoid patterns for nociceptive processing in mPGES‐1‐deficient mice. Journal of Cellular and Molecular Medicine. 12(2). 639–648. 28 indexed citations
16.
Knecht, Laura A., Susanne M. Gauthier, Janna C. Castro, et al.. (2006). Diabetes care in the hospital: Is there clinical inertia?. Journal of Hospital Medicine. 1(3). 151–160. 95 indexed citations
17.
Schmidt, Helmut, Ronald Schmidt, & Gerd Geißlinger. (2006). LC–MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. Prostaglandins & Other Lipid Mediators. 81(3-4). 162–170. 58 indexed citations
18.
Schmidt, Ronald, Ovidiu Coste, & Gerd Geißlinger. (2005). LC–MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. Journal of Chromatography B. 826(1-2). 188–197. 58 indexed citations
19.
Maier, Thorsten J., et al.. (2004). Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Biochemical Pharmacology. 67(8). 1469–1478. 154 indexed citations
20.
Morrish, Donald W., et al.. (1990). 131I treatment of thyroid papillary carcinoma in a patient with renal failure. Cancer. 66(12). 2509–2513. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhonghua Qi Breakdown of academic impact, for papers by Anca D. Dobrian Breakdown of academic impact, for papers by Nigishi Hotta Breakdown of academic impact, for papers by Nicole Helbecque Breakdown of academic impact, for papers by Martin McIntyre Breakdown of academic impact, for papers by Atsuo Goto Breakdown of academic impact, for papers by Akira Uruno Breakdown of academic impact, for papers by Nobuo Sakamoto Breakdown of academic impact, for papers by Harry S. Margolius Breakdown of academic impact, for papers by Yuning Huang
Rankless by CCL
2026